title: The Lebanese Society for Infectious Diseases and Clinical Microbiology (LSIDCM) guidelines for adult community-acquired pneumonia (Cap) in Lebanon.
abstract: Adult community-acquired pneumonia (CAP) is a common cause of morbidity and mortality which is managed by different disciplines in a heterogeneous fashion. Development of consensus guidelines to standardize these wide variations in care has become a prime objective. The Lebanese Society of Infectious Diseases and Clinical Microbiology (LSIDCM) convened to set Lebanese national guidelines for the management of CAP since it is a major and a prevalent disease affecting the Lebanese population. These guidelines, besides being helpful in direct clinical practice, play a major role in establishing stewardship programs in hospitals in an effort to contain antimicrobial resistance on the national level. These guidelines are intended for primary care practitioners and emergency medicine physicians. They constitute an appropriate starting point for specialists' consultation being based on the available local epidemiological and resistance data. This document includes the following: 1/ Rationale and scope of the guidelines; 2/ Microbiology of CAP based on Lebanese data; 3/ Clinical presentation and diagnostic workup of CAP; 4/ Management and prevention strategies based on the IDSA/ATS Consensus Guidelines, 2007, and the ESCMID Guidelines, 2011, and tailored to the microbiological data in Lebanon; 5/ Comparison to regional guidelines. The recommendations made in this document were graded based on the strength of the evidence as in the 2007 IDSA/ATS Consensus Guidelines. Hopefully, these guidelines will be an important step towards standardization of CAP care in Lebanon and set the agenda for further research in this area.
authors.forename: Rima
authors.initials: R
authors.lastname: Moghnieh
authors.forename: Nadine
authors.initials: N
authors.lastname: Yared Sakr
authors.forename: Souha S
authors.initials: SS
authors.lastname: Kanj
authors.forename: Umayya
authors.initials: U
authors.lastname: Musharrafieh
authors.forename: Rula
authors.initials: R
authors.lastname: Husni
authors.forename: Mona
authors.initials: M
authors.lastname: Jradeh
authors.forename: Ghassan
authors.initials: G
authors.lastname: Al-Awar
authors.forename: Madona
authors.initials: M
authors.lastname: Matar
authors.forename: Wafa
authors.initials: W
authors.lastname: Jureij
authors.forename: Saad
authors.initials: S
authors.lastname: Antoine
authors.forename: Eid
authors.initials: E
authors.lastname: Azar
authors.forename: Pierre
authors.initials: P
authors.lastname: Abi Hanna
authors.forename: Afaf
authors.initials: A
authors.lastname: Minari
authors.forename: Jamale
authors.initials: J
authors.lastname: Hammoud
authors.forename: Joumana
authors.initials: J
authors.lastname: Kfoury
authors.forename: Tahsin
authors.initials: T
authors.lastname: Mahfouz
authors.forename: Diaa
authors.initials: D
authors.lastname: Abou Chakra
authors.forename: Mohamad
authors.initials: M
authors.lastname: Zaatari
authors.forename: Zuhayr A
authors.initials: ZA
authors.lastname: Tabbarah
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology* / Q000517:prevention & control; D024901:Drug Resistance, Multiple, Bacterial; D004636:Emergency Service, Hospital; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007861:Lebanon; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010343:Patient Admission / Q000706:statistics & numerical data; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology* / Q000517:prevention & control; D011320:Primary Health Care; D016032:Randomized Controlled Trials as Topic
chemical_list: D000900:Anti-Bacterial Agents